9:22 AM
Leo Group India
| ||
| Pharmaceutical Company Sues Taskforce On Counterfeit Drugs P.M. News In a bid to redress the injustice alleged to have been meted out to them, two Directors of a pharmaceutical company, Mr. Samuel Ediu and Superintendent pharmacist, Alexander Ani Eton and their company, Edichart Investment Limited, have renewed their ... See all stories on this topic » | ||
| Suit: Firm Provided Tainted Meds in 2002, Man Died Pharmaceutical Processing Earlier this summer, a separate pharmaceutical firm with common owners was accused of failing to separate sterile and non-sterile supplies. That pharmaceutical company was shut down Wednesday for inspections, the latest example of fallout from the ... See all stories on this topic » | ||
| Launch of IBEF Publication - The Best of India in Pharmaceuticals SME Times MADRID and GURGAON, India: The India Brand Equity Foundation (IBEF) publication titled 'The Best of India in Pharmaceuticals' was released last evening at the Innovation Awards at CPhI Worldwide by Mr S R Rao, Commerce Secretary, Ministry of ... See all stories on this topic » | ||
| ScripsAmerica Becomes an Approved Vendor of Top 5 Generic Pharmaceutical ... NASDAQ Being an approved vendor enables ScripsAmerica to distribute products from the major generic pharmaceutical manufacturer to its current and future customers. The approval follows ScripsAmerica's successful completion of a screening process that ... See all stories on this topic » | ||
| TEXT-S&P cuts Pharmaceutical Product Development to 'B' Reuters Overview -- Wilmington, N.C.-based contract research organization (CRO) Pharmaceutical Product Development LLC (PPD) is issuing $500 million in notes that, together with $115 million in cash, the company will use to fund a sponsor dividend. -- Pro ... See all stories on this topic » | ||
| Somaxon Pharmaceuticals Approves 1-for-8 Reverse Stock Split and Decrease ... NASDAQ SAN DIEGO, Oct. 11, 2012 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company, today announced that its Board of Directors approved a 1-for-8 reverse stock split of its common stock and a decrease ... See all stories on this topic » | ||
| Patient Adherence Efforts Gain More Recognition throughout the Pharmaceutical ... The Herald | HeraldOnline.com RESEARCH TRIANGLE PARK, N.C. — Since 2009, US pharmaceutical companies have increased their patient adherence budgets by 281%, according to a recent study, to combat large number of unnecessary hospitalizations and even deaths that could be ... See all stories on this topic » | ||
| Valeant Pharmaceuticals PT Raised to $75.00 (VRX) Jags Report Valeant Pharmaceuticals (NYSE: VRX) had its target price lifted by Stifel Nicolaus from $60.00 to $75.00 in a report issued on Thursday. They currently have a buy rating on the stock. A number of other firms have also recently commented on VRX ... See all stories on this topic » | ||
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED : Form of proxy for use at the ... 4-traders Lee's Pharmaceutical Holdings Limited : Form of proxy for use at the Extraordinary General Meeting. 10/11/2012| 06:39am US/Eastern. Lee's Pharmaceutical Holdings Limited ? ? ? ? ? ? ? ? ? ? ? *. (incorporated in the Cayman Islands with limited ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment